New immune cell therapy tested for Tough-to-Treat cancers
NCT ID NCT07250386
Summary
This early-stage study is testing a new type of personalized immune cell therapy called CAR-T for people with advanced lung or breast cancer that has stopped responding to standard treatments. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target cancer, and then infusing them back into the body. Researchers will test different doses and two infusion methods (into a vein or the chest cavity) to find the safest approach and see if it can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital, Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310017, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.